Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories
Shares of biotech Inovio Pharmaceuticals Inc. fell more than 20% Friday, as analysts weighed in on the company’s latest earnings and RBC downgraded the stock on valuation grounds.